In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Viatris Inc. is one of them. Viatris Inc. (NASDAQ:VTRS), formed from the 2020 merger of Mylan ...

Over the past seven trading days, VTRS shed around 9%, with daily losses including a 3.61% drop on September 15 and a 2.06% slide on September 12. The stock had been under steady pressure amid broader ...

Greenlight Capital's 13F portfolio rose to $2.33B in Q2 2025. Check out the key new stakes and major increases in the ...

J.P. Morgan analyst maintained a Hold rating on Viatris today and set a price target of $14.00. The company’s shares closed yesterday at $9.60. Take advantage of TipRanks Premium at 50% off! Unlock ...

This year's top 10 highest-paid GCs in Pennsylvania (ranked by total cash) included six familiar names from last year's list, ...

Making its debut on 06/16/2017, smart beta exchange traded fund Pacer US Small Cap Cash Cows ETF (CALF) provides investors ...

Karnataka posts highest per capita income in 2025 as Azim Premji, Nikhil Kamath, and other top billionaires drive IT, biotech ...

Mapi Pharma’s injectable version of cariprazine, developed using its patented Depot technology, has demonstrated a long-acting release profile, for one monthly injection. The product is designed to ...

Investing.com -- Deutsche Bank struck a more upbeat tone on European pharmaceuticals, upgrading Alvotech to Buy from Hold while keeping its price target at $14. Shares in Alvotech rose 4.6% in U.S.

What's Going On With Bullish Shares Thursday? Bullish shares are trading higher Thursday after the company reported a year-over-year increase in second quarter financial results on Wednesday after the ...